Status:
COMPLETED
Comparison of Two Dosages of Heparin Before Extracorporeal Circulation
Lead Sponsor:
Astes
Conditions:
Extracorporeal Circulation; Complications
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
In this study the investigators will study two dosages of heparin before extracorporeal circulation in open chest cardiac surgery.
Detailed Description
In this study the investigators will study two dosages of heparin before extracorporeal circulation in open chest cardiac surgery. The first dosage will be 300 IU per kilogram of REAL weight, the seco...
Eligibility Criteria
Inclusion
- All patients admitted for cardiac open chest surgery
Exclusion
- Patient's refusal
- Antithrombin III factor \< 75%
- Patient under treatment by heparin IV
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03752437
Start Date
October 1 2019
End Date
September 30 2021
Last Update
February 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique Saint-Luc of Bouge
Namur, Belgium, 5004